US58502B1061
US58502B1061
Pediatrix Medical Group, Inc.
Loading chart...
Valuation & History
Quarterly trend of key valuation metrics
| Metric | Current (TTM) TTM Baseline | Q2 '26 30.06.2026 | Q1 '26 31.03.2026 | Q4 '25 31.12.2025 |
|---|---|---|---|---|
Market & Enterprise Value | ||||
Market Cap | 2.16B EUR | 2.06B EUR | 1.76B EUR | 1.77B EUR |
Enterprise Value | 2.3B EUR | 2.39B EUR | 2.18B EUR | 2.03B EUR |
Valuation Multiples | ||||
Trailing P/E | 12.75x | 11.77x | 10.07x | 12.27x |
Forward P/E | 10.91x | -- | -- | -- |
Price to Sales | 1.11x | 1.05x | 0.91x | 1.22x |
Price to Book | 2.4x | 2.34x | 2x | 2.05x |
EV/Revenue | 1.18x | 1.22x | 1.13x | 1.4x |
EV/EBITDA | 8.71x | 8.92x | 8.21x | 9.59x |
Price to FCF (P/FCF) | 13.46x | 9x | 7.4x | 4.75x |
EV/FCF | 14.29x | 10.45x | 9.18x | 5.45x |
FCF Yield | 7.43% | 11.11% | 13.52% | 21.04% |